SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Repositioned drugs: integrating intellectual property and regulatory strategies · Study

ArticleShelves

ArticleRepositioned drugs: integrating intellectual property and regulatory strategies

Richard B. Smith2011

Article2011

Repositioned drugs: integrating intellectual property and regulatory strategies

Richard B. Smith

64 citations·0/0 files stored·Drug Discovery Today Therapeutic Strategies

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Intellectual Property Law Intellectual Property and Patents

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 64 citations exist upstream.

Cited by

2014Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications 2021Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research 2014Tecfidera®: an Approach for Repurposing

Details

Year2011

Typearticle

Published2011-12-01

VenueDrug Discovery Today Therapeutic Strategies

ISSN-L1740-6773

Languageen

Citations64

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.ddstr.2011.06.008

openalex_workW2134900711

Links

Imported from OpenAlex (CC0) — nothing here is generated.